Aurélia Meurisse

RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study

Jean‐Baptiste Bachet, Olivier Bouché, Olivier Dubreuil et al. · Annals of Oncology · 2018 · 175 citations · Full text

Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study

Stéfano Kim, Éric François, Thierry André et al. · The Lancet Oncology · 2018 · 140 citations

Gastrointestinal Oncology, Medicine, Metronomic Therapy +6

Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial

Alice Bernard‐Tessier, Emmanuelle Jeannot, David Guenat et al. · Clinical Cancer Research · 2018 · 90 citations

RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study

Romain Cohen, Jaafar Bennouna, Aurélia Meurisse et al. · Journal for ImmunoTherapy of Cancer · 2020 · 77 citations · Full text

Result of one-year, prospective follow-up of intensive care unit survivors after SARS-CoV-2 pneumonia

Guillaume Eberst, Fréderic Claudé, Lucie Laurent et al. · Annals of Intensive Care · 2022 · 70 citations · Full text